If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
New Product Development » New Product Planning
Download FREE Excerpt
15 Info Graphics
19 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
The pharmaceutical New Product Planning function conducts activities that create a picture for how a new product will perform in the marketplace if it is approved by the FDA. For instance in the early stages of development, the NPP function will perform patient segmentation research to clarify what patients will benefit most from a potential therapy. Patient segmentation is just one of several types of market research studies that the NPP role will do for products in development.
Best Practices, LLC undertook this benchmarking study to provide NPP leaders with pharma industry benchmarks on when organizations conduct key market research activities for new products. The study also provides an overview of the current state of NPP in pharma and key patterns in NPP activities during the development process.
For this research project, Best Practices, LLC engaged 19 leaders from 15 leading pharmaceutical, biotech, and life sciences companies.
Biopharmaceutical; Pharmaceutical; Medical Device; Biotech; Health Care; Clinical Research; Laboratories; Manufacturing; Consumer Products; Diagnostic
Alkermes; Zydus Cadila; GlaxoSmithKline ; Astellas; Roche; Novartis; Sanofi; Pfizer; Takeda Pharmaceuticals; Cytokinetics; Allergan; Medicago; Bayer; Galderma; Wockhardt